Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study)
Table 4
Changes in residual urine volume and QT interval in the short-term analysis set.
Variable
Imidafenacin
Solifenacin
Number of subjects
17
18
Residual urine volume (mL)
0 week
(Mean ± SD)
4 week
(Mean ± SD)
NS
12 week
(Mean ± SD)
NS
QT interval (ms)
0 week
(Mean ± SD)
4 week
(Mean ± SD)
NS
12 week
(Mean ± SD)
NS
Intragroup (versus 0 weeks: the end of the observation period) Paired t-test *: , **: Intergroup: unpaired t-test, NS: not significant, SD: standard deviation.